🇺🇸 FDA
Pipeline program

-, -, SULFAMETHOXAZOLE AND TRIMETHOPRIM

APHP200020

Approved small_molecule active

Quick answer

-, -, SULFAMETHOXAZOLE AND TRIMETHOPRIM for Pyelonephritis, Kidney Transplant recipients is a Approved program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Pyelonephritis, Kidney Transplant recipients
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials